Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasclinical-pharmacology-and-therapeutics

Paeds Vivas · clinical-pharmacology-and-therapeutics

Therapeutic drug monitoring — branching viva

Branching viva on therapeutic drug monitoring in children: choosing the vancomycin area-under-the-curve target and sampling time, recognising augmented renal clearance in PICU, and defending the nonlinear Michaelis-Menten kinetics and free-fraction reasoning that govern a toxic phenytoin level in a hypoalbuminaemic child.

branching clinical structured oral3 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A ward call about a six-year-old on intravenous vancomycin for a complicated MRSA bacteraemia whose trough has come back lower than expected. The examiner asks you to state the target, the sampling time, and how you would interpret the result — then branches to the augmented-renal-clearance child in PICU, and finally to a nine-year-old on long-term phenytoin with a total level of 28 mg/L, hypoalbuminaemia, nystagmus and ataxia that forces the nonlinear-kinetics and free-fraction discussion.

Opening — the vancomycin level on the ward

Examiner: A six-year-old on intravenous vancomycin for a complicated MRSA bacteraemia has a trough back. What is your monitoring target, and when should the level have been drawn? [1]

Candidate (model): For serious MRSA infection my target is the 24-hour area under the concentration–time curve over the MIC — an AUC₂₄/MIC of 400 or more — as set by the 2020 ASHP, IDSA, PIDS and SIDP consensus guideline. AUC-guided monitoring, by two timed levels or Bayesian forecasting from a single level, is preferred over a trough-only strategy because it achieves target exposure with less nephrotoxicity. A true trough is drawn within 30 to 60 minutes before the next dose, at steady state — about the fourth dose in an older child — and not during the infusion or from the infusing line. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Rybak MJ, Le J, Lodise TP, et al. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review. Clin Infect Dis, 2020.PMID 32658968
  2. [2]He CY, Ye PP, Liu B, et al. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance. Antimicrob Agents Chemother, 2021.PMID 34339268
  3. [8]Ludden TM Nonlinear pharmacokinetics: clinical Implications. Clin Pharmacokinet, 1991.PMID 2044328
  4. [9]Patsalos PN, Zugman M, Lake C, et al. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations. Epilepsia, 2017.PMID 28542801
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSafe prescribing, administration and monitoring — branching vivaclinical-pharmacology-and-therapeuticsNextVaccines and immunobiology — branching vivaclinical-pharmacology-and-therapeutics